During the past decade, Women's Health Advantage conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 2 clinical trials were completed, i.e. on average, 13.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Women's Health Advantage" #1 sponsor was "ASTORA Women's Health" with 2 trials, followed by "Coloplast A/S" with 2 trials sponsored, "Femasys Inc." with 2 trials sponsored, "Sebela Women's Health Inc." with 2 trials sponsored and "Abbott Molecular" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Women's Health Advantage" #1 collaborator was "PRA Health Sciences" with 1 trials as a collaborator and "Synteract, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Women's Health Advantage" are "Contraception" (4 trials), "Pelvic Organ Prolapse" (3 trials), "Women at Risk for Pregnancy" (2 trials), "Human Papillomavirus" (1 trials) and "Menorrhagia" (1 trials). Many other conditions were trialed in "Women's Health Advantage" in a lesser frequency.

Most popular intervention types in "Women's Health Advantage" are "Device" (10 trials), "Procedure" (5 trials), "Drug" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "FemBloc" (2 trials), "Native Tissue Repair for pelvic organ prolapse" (2 trials), "Alinity m HR HPV" (1 trials), "Altis Sling" (1 trials) and "Blood draw" (1 trials). Other intervention names were less common.

The vast majority of trials in "Women's Health Advantage" are 12 trials for "Female" genders and 3 trials for "All" genders.

Currently, there are NaN active trials in "Women's Health Advantage". 1 are not yet recruiting, 2 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Women's Health Advantage, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Women's Health Advantage, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 6 trials that are defined as “Not Applicable".